Emergence of exosomal miRNAs as a diagnostic biomarker for Alzheimer's disease
暂无分享,去创建一个
[1] Y. Tong,et al. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease. , 2015, Journal of Alzheimer's disease : JAD.
[2] S. An,et al. Role of apolipoprotein E in neurodegenerative diseases , 2015, Neuropsychiatric disease and treatment.
[3] W. Lukiw,et al. microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease , 2015, Front. Neurol..
[4] S. An,et al. Gene panels and primers for next generation sequencing studies on neurodegenerative disorders , 2015, Molecular & Cellular Toxicology.
[5] R. Petersen,et al. Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study , 2015, Alzheimer's & Dementia.
[6] Jeong Ah Kim,et al. In situ single step detection of exosome microRNA using molecular beacon. , 2015, Biomaterials.
[7] Xi Chen,et al. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease , 2015, Disease markers.
[8] Christine S. Siegismund,et al. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease , 2015, PloS one.
[9] R. Petersen,et al. Low neural exosomal levels of cellular survival factors in Alzheimer’s disease , 2015, Annals of clinical and translational neurology.
[10] Ilona B. Bruinsma,et al. MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid , 2015, Molecular Neurobiology.
[11] Christina Backes,et al. MicroRNA in vitro diagnostics using immunoassay analyzers. , 2015, Clinical chemistry.
[12] A. Zepeda,et al. Identification of age- and disease-related alterations in circulating miRNAs in a mouse model of Alzheimer's disease , 2015, Front. Cell. Neurosci..
[13] M. Turner,et al. Identification of distinct circulating exosomes in Parkinson's disease , 2015, Annals of clinical and translational neurology.
[14] Rajan P Kulkarni,et al. Rapid inertial solution exchange for enrichment and flow cytometric detection of microvesicles. , 2015, Biomicrofluidics.
[15] T. Tuschl,et al. Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. , 2015, The Journal of clinical investigation.
[16] D. Wong,et al. Detection of exosomal biomarker by electric field-induced release and measurement (EFIRM). , 2015, Journal of visualized experiments : JoVE.
[17] Artur Lichtenberg,et al. An Innovative Method for Exosome Quantification and Size Measurement , 2015, Journal of visualized experiments : JoVE.
[18] Shumpei Niida,et al. MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer’s Disease from Public Data , 2015, Biomarker insights.
[19] A. Hill,et al. The Neutral Sphingomyelinase Pathway Regulates Packaging of the Prion Protein into Exosomes* , 2014, The Journal of Biological Chemistry.
[20] Rochelle Buffenstein,et al. Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice , 2014, Front. Mol. Neurosci..
[21] B. Strooper,et al. Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: The need of larger datasets , 2014, Ageing Research Reviews.
[22] Wei Zhang,et al. Genome-Wide Analysis of miRNA Signature in the APPswe/PS1ΔE9 Mouse Model of Alzheimer's Disease , 2014, PloS one.
[23] Clotilde Théry,et al. Biogenesis and secretion of exosomes. , 2014, Current opinion in cell biology.
[24] Gunhild Waldemar,et al. The potential of microRNAs as biofluid markers of neurodegenerative diseases – a systematic review , 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[25] H. Shill,et al. Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology , 2014, PloS one.
[26] Hakho Lee,et al. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor , 2014, Nature Biotechnology.
[27] M. Wildung,et al. Extracellular Vesicles in Luminal Fluid of the Ovine Uterus , 2014, PloS one.
[28] E. Wang,et al. Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma , 2014, Front. Mol. Neurosci..
[29] Nan Hu,et al. Circulating miR-125b as a biomarker of Alzheimer's disease , 2014, Journal of the Neurological Sciences.
[30] Lesley Cheng,et al. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood , 2014, Journal of extracellular vesicles.
[31] K. Blennow,et al. Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease , 2013, Neurology.
[32] Lesley Cheng,et al. The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies , 2013, Front. Genet..
[33] D. Walsh,et al. De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease. , 2013, Human molecular genetics.
[34] Sabine C. Mueller,et al. A blood based 12-miRNA signature of Alzheimer disease patients , 2013, Genome Biology.
[35] Oana A. Tomescu,et al. More than cell dust: microparticles isolated from cerebrospinal fluid of brain injured patients are messengers carrying mRNAs, miRNAs, and proteins. , 2013, Journal of neurotrauma.
[36] Zoltan Dezso,et al. Circulating miRNA Biomarkers for Alzheimer's Disease , 2013, Alzheimer's & Dementia.
[37] F. Peruzzi,et al. Cerebrospinal fluid miRNA profile in HIV‐encephalitis , 2013, Journal of cellular physiology.
[38] C. Rowe,et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.
[39] A. Saykin,et al. Neuroimaging and other biomarkers for Alzheimer's disease: the changing landscape of early detection. , 2013, Annual review of clinical psychology.
[40] Patrick C. N. Rensen,et al. Cryo-electron microscopy of extracellular vesicles in fresh plasma , 2013, Journal of extracellular vesicles.
[41] W. Lukiw,et al. microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.
[42] Mahdieh Khosroheidari,et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. , 2012, Kidney international.
[43] M. Mullan,et al. Plasma microRNA biomarkers for detection of mild cognitive impairment , 2012, Aging.
[44] M. Kurosaka,et al. Stem Cell Transplantation in Amyotrophic Lateral Sclerosis Patients: Methodological Approach, Safety, and Feasibility , 2012, Cell transplantation.
[45] J. Trojanowski,et al. TMEM106B, the Risk Gene for Frontotemporal Dementia, Is Regulated by the microRNA-132/212 Cluster and Affects Progranulin Pathways , 2012, The Journal of Neuroscience.
[46] S. Lim,et al. Proteolytic Potential of the MSC Exosome Proteome: Implications for an Exosome-Mediated Delivery of Therapeutic Proteasome , 2012, International journal of proteomics.
[47] W. Lukiw,et al. Spreading of Alzheimer's disease inflammatory signaling through soluble micro‐RNA , 2012, Neuroreport.
[48] Paul Harrison,et al. Classification, Functions, and Clinical Relevance of Extracellular Vesicles , 2012, Pharmacological Reviews.
[49] G. Jicha,et al. Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease , 2012, Experimental Neurology.
[50] N. Schonrock,et al. MicroRNA networks surrounding APP and amyloid-β metabolism — Implications for Alzheimer's disease , 2012, Experimental Neurology.
[51] J. Satoh. Molecular network of microRNA targets in Alzheimer's disease brains , 2012, Experimental Neurology.
[52] P. Kenny,et al. MicroRNAs in neuronal function and dysfunction , 2012, Trends in Neurosciences.
[53] Winston Patrick Kuo,et al. Impact of Biofluid Viscosity on Size and Sedimentation Efficiency of the Isolated Microvesicles , 2012, Front. Physio..
[54] A. Hill,et al. Exosomes: Vehicles for the Transfer of Toxic Proteins Associated with Neurodegenerative Diseases? , 2012, Front. Physio..
[55] Richard J Simpson,et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. , 2012, Methods.
[56] F. Hamdy,et al. Changes in circulating microRNA levels associated with prostate cancer , 2012, British Journal of Cancer.
[57] Richard J. Simpson,et al. ExoCarta as a resource for exosomal research , 2012, Journal of extracellular vesicles.
[58] Paul J. Harrison,et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.
[59] H. Rosenmann. CSF Biomarkers for Amyloid and Tau Pathology in Alzheimer's Disease , 2011, Journal of Molecular Neuroscience.
[60] Ger J.A. Arkesteijn,et al. Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles , 2011, Nanomedicine: Nanotechnology, Biology and Medicine.
[61] Suresh Mathivanan,et al. ExoCarta 2012: database of exosomal proteins, RNA and lipids , 2011, Nucleic Acids Res..
[62] Chris Gardiner,et al. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission , 2011, Neurobiology of Disease.
[63] H. Kettenmann,et al. Physiology of microglia. , 2011, Physiological reviews.
[64] G. Lachenal,et al. Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity , 2011, Molecular and Cellular Neuroscience.
[65] Peter T. Nelson,et al. Patterns of microRNA expression in normal and early Alzheimer’s disease human temporal cortex: white matter versus gray matter , 2011, Acta Neuropathologica.
[66] Vladimir I. Vladimirov,et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders , 2010, Schizophrenia Research.
[67] Jessica A. Weber,et al. The microRNA spectrum in 12 body fluids. , 2010, Clinical chemistry.
[68] Markus Tolnay,et al. The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.
[69] T. Preiss,et al. Neuronal MicroRNA Deregulation in Response to Alzheimer's Disease Amyloid-β , 2010, PloS one.
[70] Menggui Huang,et al. Wnt1-cre-mediated conditional loss of Dicer results in malformation of the midbrain and cerebellum and failure of neural crest and dopaminergic differentiation in mice. , 2010, Journal of molecular cell biology.
[71] J. Satoh,et al. Aberrant microRNA expression in the brains of neurodegenerative diseases: miR‐29a decreased in Alzheimer disease brains targets neurone navigator 3 , 2010, Neuropathology and applied neurobiology.
[72] M. Ntzouni,et al. Cell-Produced α-Synuclein Is Secreted in a Calcium-Dependent Manner by Exosomes and Impacts Neuronal Survival , 2010, The Journal of Neuroscience.
[73] Deming Zhao,et al. Cellular prion protein released on exosomes from macrophages binds to Hsp70. , 2010, Acta biochimica et biophysica Sinica.
[74] Xi-sha Chen,et al. MicroRNA‐146a and Human Disease , 2010, Scandinavian journal of immunology.
[75] N. Aronin,et al. Aberrant Rab11-Dependent Trafficking of the Neuronal Glutamate Transporter EAAC1 Causes Oxidative Stress and Cell Death in Huntington's Disease , 2010, The Journal of Neuroscience.
[76] T. D. de Gruijl,et al. Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.
[77] Michael Schmidt,et al. Structural-mechanical characterization of nanoparticle exosomes in human saliva, using correlative AFM, FESEM, and force spectroscopy. , 2010, ACS nano.
[78] T. Wurdinger,et al. Microfluidic isolation and transcriptome analysis of serum microvesicles. , 2010, Lab on a chip.
[79] Juan Nunez-Iglesias,et al. Joint Genome-Wide Profiling of miRNA and mRNA Expression in Alzheimer's Disease Cortex Reveals Altered miRNA Regulation , 2010, PloS one.
[80] J. Klein,et al. Microfiltration isolation of human urinary exosomes for characterization by MS , 2010, Proteomics. Clinical applications.
[81] K. Kosik,et al. MicroRNAs Potentiate Neural Development , 2009, Neuron.
[82] T. Sun,et al. Different timings of dicer deletion affect neurogenesis and gliogenesis in the developing mouse central nervous system , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.
[83] Richard Wade-Martins,et al. LRRK2 regulates autophagic activity and localizes to specific membrane microdomains in a novel human genomic reporter cellular model. , 2009, Human molecular genetics.
[84] Peng Liu,et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation , 2009, Brain Research Bulletin.
[85] J. Im,et al. Repression of α-synuclein expression and toxicity by microRNA-7 , 2009, Proceedings of the National Academy of Sciences.
[86] C. Théry,et al. Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.
[87] Trairak Pisitkun,et al. Large-scale proteomics and phosphoproteomics of urinary exosomes. , 2009, Journal of the American Society of Nephrology : JASN.
[88] Jacopo Meldolesi,et al. Shedding microvesicles: artefacts no more. , 2009, Trends in cell biology.
[89] Yi Xing,et al. The Bifunctional microRNA miR-9/miR-9* Regulates REST and CoREST and Is Downregulated in Huntington's Disease , 2008, The Journal of Neuroscience.
[90] Lianbo Yu,et al. Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.
[91] J. Schorey,et al. The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis. , 2008, Glycobiology.
[92] R. Vassar,et al. The Role of Amyloid Precursor Protein Processing by BACE1, the β-Secretase, in Alzheimer Disease Pathophysiology* , 2008, Journal of Biological Chemistry.
[93] G. Raposo,et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles , 2008, Biology of the cell.
[94] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[95] V. Scheinker,et al. Transrenal Nucleic Acids: From Proof of Principle to Clinical Tests , 2008, Annals of the New York Academy of Sciences.
[96] Daniel B. Martin,et al. Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.
[97] A. Delacourte,et al. Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.
[98] Elena Cattaneo,et al. A microRNA-based gene dysregulation pathway in Huntington's disease , 2008, Neurobiology of Disease.
[99] Guiliang Tang,et al. The Expression of MicroRNA miR-107 Decreases Early in Alzheimer's Disease and May Accelerate Disease Progression through Regulation of β-Site Amyloid Precursor Protein-Cleaving Enzyme 1 , 2008, The Journal of Neuroscience.
[100] P. Altevogt,et al. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis , 2007, Neuroscience Letters.
[101] P. Altevogt,et al. CD24 is a marker of exosomes secreted into urine and amniotic fluid. , 2007, Kidney international.
[102] G. Hannon,et al. A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons , 2007, Science.
[103] Riitta Lahesmaa,et al. Exosomes with Immune Modulatory Features Are Present in Human Breast Milk1 , 2007, The Journal of Immunology.
[104] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[105] Trairak Pisitkun,et al. Rapid isolation of urinary exosomal biomarkers using a nanomembrane ultrafiltration concentrator. , 2007, American journal of physiology. Renal physiology.
[106] R. Cappai,et al. Packaging of prions into exosomes is associated with a novel pathway of PrP processing , 2007, The Journal of pathology.
[107] Joel S Parker,et al. microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder , 2007, Genome Biology.
[108] R. J. Kelleher,et al. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism , 2007, Proceedings of the National Academy of Sciences.
[109] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[110] G. Raposo,et al. Exosomes: a common pathway for a specialized function. , 2006, Journal of biochemistry.
[111] J. Dear,et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. , 2006, Kidney international.
[112] H. Schluesener,et al. Role of exosomes in immune regulation , 2006, Journal of cellular and molecular medicine.
[113] G. Lachenal,et al. Exosomes are released by cultured cortical neurones , 2006, Molecular and Cellular Neuroscience.
[114] A. Booth,et al. Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane , 2006, The Journal of cell biology.
[115] Aled Clayton,et al. Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids , 2006, Current protocols in cell biology.
[116] K. Blennow,et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study , 2006, The Lancet Neurology.
[117] Sibel Akyol,et al. Pregnancy-Associated Exosomes and Their Modulation of T Cell Signaling1 , 2006, The Journal of Immunology.
[118] M. Record,et al. Characterization of exosome subpopulations from RBL-2H3 cells using fluorescent lipids. , 2005, Blood cells, molecules & diseases.
[119] Graça Raposo,et al. Exosomal-like vesicles are present in human blood plasma. , 2005, International immunology.
[120] Dominic M. Walsh,et al. Deciphering the Molecular Basis of Memory Failure in Alzheimer's Disease , 2004, Neuron.
[121] Rong-Fong Shen,et al. Identification and proteomic profiling of exosomes in human urine. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[122] W. Faigle,et al. Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[123] Sébastien Roy,et al. Mast cell- and dendritic cell-derived exosomes display a specific lipid composition and an unusual membrane organization. , 2004, The Biochemical journal.
[124] V. Ambros,et al. Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation , 2004, Genome Biology.
[125] Konstantin Khrapko,et al. A microRNA array reveals extensive regulation of microRNAs during brain development. , 2003, RNA.
[126] J. Thyberg,et al. Exosomes with major histocompatibility complex class II and co-stimulatory molecules are present in human BAL fluid , 2003, European Respiratory Journal.
[127] J. Slot,et al. Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.
[128] J. Le Pecq,et al. Production and characterization of clinical grade exosomes derived from dendritic cells. , 2002, Journal of immunological methods.
[129] A. Levey,et al. Huntingtin-associated Protein 1 Interacts with Hepatocyte Growth Factor-regulated Tyrosine Kinase Substrate and Functions in Endosomal Trafficking* , 2002, The Journal of Biological Chemistry.
[130] Laurence Zitvogel,et al. Exosomes: composition, biogenesis and function , 2002, Nature Reviews Immunology.
[131] A. Régnault,et al. TCR Activation of Human T Cells Induces the Production of Exosomes Bearing the TCR/CD3/ζ Complex1 , 2002, The Journal of Immunology.
[132] G. Raposo,et al. Intestinal epithelial cells secrete exosome-like vesicles. , 2001, Gastroenterology.
[133] S. Prusiner,et al. Shattuck lecture--neurodegenerative diseases and prions. , 2001, The New England journal of medicine.
[134] M. DiFiglia,et al. Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy , 2000, The Journal of Neuroscience.
[135] Laurence Zitvogel,et al. Molecular Characterization of Dendritic Cell-Derived Exosomes , 1999, The Journal of cell biology.
[136] Manho Kim,et al. Are there multiple pathways in the pathogenesis of Huntington's disease? , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[137] H. Geuze,et al. Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.
[138] Laurence Zitvogel,et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes , 1998, Nature Medicine.
[139] G. Raposo,et al. Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation. , 1997, Molecular biology of the cell.
[140] C. Melief,et al. B lymphocytes secrete antigen-presenting vesicles , 1996, The Journal of experimental medicine.
[141] R. Johnstone,et al. Vesicle formation during reticulocyte maturation. Association of plasma membrane activities with released vesicles (exosomes). , 1987, The Journal of biological chemistry.
[142] M. Adam,et al. Electron microscopic evidence for externalization of the transferrin receptor in vesicular form in sheep reticulocytes , 1985, The Journal of cell biology.
[143] P. Stahl,et al. Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes , 1983, The Journal of cell biology.
[144] C. Reyero,et al. Isolation of porcine colostral immunoglobulins and preparation of monospecific anti-γ, anti-α, and anti-μ chain antibodies using agarose-linked immunosorbents , 1977 .
[145] Maire Peters,et al. Comparison of serum exosome isolation methods for microRNA profiling. , 2014, Clinical biochemistry.
[146] Peter T Nelson,et al. A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. , 2013, Journal of Alzheimer's disease : JAD.
[147] C. Rowe,et al. Increasing the predictive accuracy of amyloid-β blood-borne biomarkers in Alzheimer's disease. , 2011, Journal of Alzheimer's disease : JAD.
[148] P. Nelson,et al. MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study. , 2010, Journal of Alzheimer's disease : JAD.
[149] Miguel C. Seabra,et al. Rab27a and Rab27b control different steps of the exosome secretion pathway , 2010, Nature Cell Biology.
[150] N. Wang,et al. Isolation and purification of exosomes in urine. , 2010, Methods in molecular biology.
[151] A. Roses,et al. Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .
[152] A. Minagar,et al. Cell-derived microparticles and exosomes in neuroinflammatory disorders. , 2007, International review of neurobiology.
[153] M. Mason,et al. Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry. , 2001, Journal of immunological methods.
[154] J. Hardy,et al. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. , 1991, Trends in pharmacological sciences.